Endoscopic submucosal dissection of recurrent or residual superficial esophageal cancer after chemoradiotherapy

Background Treatment of local recurrent or residual superficial esophageal squamous-cell carcinoma (SCC) with conventional EMR often results in a piecemeal resection that requires further intervention. Objective The aim of this study was to evaluate the efficacy of endoscopic submucosal dissection (...

Full description

Saved in:
Bibliographic Details
Published inGastrointestinal endoscopy Vol. 67; no. 2; pp. 355 - 359
Main Authors Saito, Yutaka, MD, PhD, Takisawa, Hajime, MD, Suzuki, Haruhisa, MD, Takizawa, Kouhei, MD, Yokoi, Chizu, MD, Nonaka, Satoru, MD, Matsuda, Takahisa, MD, Nakanishi, Yukihiro, MD PhD, Kato, Ken, MD
Format Journal Article
LanguageEnglish
Published New York, NY Mosby, Inc 01.02.2008
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background Treatment of local recurrent or residual superficial esophageal squamous-cell carcinoma (SCC) with conventional EMR often results in a piecemeal resection that requires further intervention. Objective The aim of this study was to evaluate the efficacy of endoscopic submucosal dissection (ESD). Design A case series. Patients Between January 2006 and September 2006, 4 local recurrent or residual superficial esophageal SCCs were treated by ESD. Interventions ESD procedures were performed by using a bipolar needle knife and an insulation-tipped knife. After injection of glycerol into the submucosal (sm) layer, a circumferential incision was made, and an sm dissection was performed. All lesions were determined to be intramucosal or sm superficial, without lymph-node metastasis by EUS before treatment. Main Outcome Measurements Tumor size, en bloc resection rate, tumor-free lateral margin rates, and complications were recorded. Results All 4 ESD cases were successfully resected en bloc, and the tumor-free lateral margin rate was 75% (3/4) by histopathology examination. The mean tumor size of the resected specimens was 35 mm (range, 15-50 mm). There were no complications. Limitations The number of ESDs in our series was limited, and there are no long-term follow-up data. Conclusions ESD for recurrent or residual superficial esophageal tumors after chemoradiotherapy achieves the goal of an en bloc resection, with a low rate of incomplete treatment without any greater risk than the EMR technique.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0016-5107
1097-6779
DOI:10.1016/j.gie.2007.10.008